name | lbj |
sex | female
|
age | 72 岁 |
hospital number | 858043 |
height | 158 cm |
weight | 65 kg |
BSA | 1.66 m2 |
APACHEⅡ | 18 分 |
Infection source | lung
|
date | 2017/12/26 年/月/日 |
Sequential Organ Failure Assessment | 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
比阿培南0.6g ivgtt q12h |
|
vasoactive agent | norepinephrine
|
100 min |
|
180 min |
|
160 min |
Temperature | 37.2 ℃ |
Heart Rate | 75 次/分 |
Breath | 18 次/分 |
Systolic pressure (SP) | 108 mmHg |
Diastolic pressure | 53 mmHg |
mean arterial pressure | 68 mmHg |
Pcv-aCO2 | 4.4 mmHg |
DO2 | 394.73 |
VO2 | 7.75 |
Ca-vO2 | 2.43 |
pH value | 7.45 |
PaO2 | 62.2 mmHg |
PaCO2 | 33.6 mmHg |
BE | -0.4 mmol/L(±2.3mmol/L) |
SaO2 | 91.5 % |
Blood lactic acid concentration, LAC | 2.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 155.50 mmHg |
pH value | 7.31 |
PcvO2 | 41.7 mmHg |
PcvCO2 | 38 mmHg |
BE | -6.5 mmol/L |
ScvO2 | 89.70 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.21 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 10 mmHg |
cardiac output | 3.28 L/min |
cardiac index | 1.98 L/min/m2 |
stroke volume | 43.7 ml |
Stroke Index | 36.3 ml/m2 |
ITBVI | 736 ml/m2 |
GEDVI | 589 ml/m2 |
EVLWI | 7.9 ml/kg |
PVPI | 2 |
SVRI | 3237 DSm2/cm5 |
CFI | 3 |
GEF | 18 % |
SVV | 4 % |
PPV | % |
dPmax | 690 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 2 条 |
LUS | 8 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 23 mm |
IVC(expiratory phase) | 20 mm |
respiratory variations of inferior vena cavae diameter | 13.95 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 20 mm |
IVC(expiratory phase) | 18 mm |
Respiratory variations of inferior vena cavae diameter | 10.53 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 36.8 ℃ |
Heart Rate | 76 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 126 mmHg |
Diastolic Pressure | 72 mmHg |
Mean Arterial Pressure | 85 mmHg |
Pcv-aCO2 | 8.80 mmHg |
DO2 | 340.09 |
VO2 | 12.8 |
Ca-vO2 | 4.85 |
PH value | 7.46 |
PaO2 | 69.1 mmHg |
PaCO2 | 29 mmHg |
BE | -2.8 mmol/L |
SaO2 | 95.5 % |
Blood Lactic Acid Concentration | 2.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 172.75 mmHg |
PH value | 7.49 |
PcvO2 | 45.1 mmHg |
PcvCO2 | 37.8 mmHg |
BE | -1.8 mmol/L |
ScvO2 | 91.9 % |
Volume of input | 1290 ml |
Volume of output | 1050 ml |
Volume of urine | 1000 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 2 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 5 mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 2.68 L/min |
cardiac index | 1.61 L/min/m2 |
stroke volume | 35.3 ml |
Stroke Index | 21.2 ml/m2 |
ITBVI | 749 ml/m2 |
GEDVI | 600 ml/m2 |
EVLWI | 9.1 ml/kg |
PVPI | 2.3 |
SVRI | 4804 DSm2/cm5 |
CFI | 3 |
GEF | 14 % |
SVV | 5 % |
PPV | % |
dPmax | 653 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 3 条 |
LUS | 8 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.2 ℃ |
Heart Rate | 76 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 112 mmHg |
Diastolic Pressure | 62 mmHg |
Mean Arterial Pressure | 78 mmHg |
Pcv-aCO2 | 1.3 mmHg |
DO2 | 316.74 |
VO2 | 11.25 |
Ca-vO2 | 4.69 |
PH value | 7.41 |
PaO2 | 73 mmHg |
PaCO2 | 28.7 mmHg |
BE | -2.2 mmol/L |
SaO2 | 95.60 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 182.5 mmHg |
PH value | 7.45 |
PcvO2 | 60 mmHg |
PcvCO2 | 30 mmHg |
BE | -3.8 mmol/L |
ScvO2 | 92.2 % |
Volume of input | 1500 ml |
Volume of output | 1200 ml |
Volume of urine | 1200 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 8 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 10 mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 2.42 L/min |
cardiac index | 1.46 L/min/m2 |
stroke volume | 31.8 ml |
Stroke Index | 19.2 ml/m2 |
ITBVI | 669 ml/m2 |
GEDVI | 535 ml/m2 |
EVLWI | 9.8 ml/kg |
PVPI | 2.8 |
SVRI | 4772 DSm2/cm5 |
CFI | 3 |
GEF | 14 % |
SVV | 4 % |
PPV | % |
dPmax | 652 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 1 条 |
LUS | 6 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19 mm |
IVC(expiratory phase) | 17 mm |
Respiratory variations of inferior vena cavae diameter | 11.11 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 2.9 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 12.95 |
PH value | 7.48 |
PaO2 | 80.4 mmHg |
PaCO2 | 25.2 mmHg |
BE | -4 mmol/L |
SaO2 | 97.10 % |
Blood Lactic Acid Concentration | 1 mmol/L |
Oxygenation index (PaO2/FiO2) | 201.0 mmHg |
PH value | 7.48 |
PcvO2 | 47.8 mmHg |
PcvCO2 | 28.1 mmHg |
BE | -1.8 mmol/L |
ScvO2 | 87.7 % |
Volume of input | 1720 ml |
Volume of output | 1700 ml |
Volume of urine | 1750 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 8 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 15 mg |
Levosimendan | no
|
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | mm |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 4.40 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 13.01 |
PH value | 7.48 |
PaO2 | 99.8 mmHg |
PaCO2 | 25.7 mmHg |
BE | -3.8 mmol/L |
SaO2 | 98.6 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 249.50 mmHg |
PH value | 7.52 |
PcvO2 | 50.1 mmHg |
PcvCO2 | 30.1 mmHg |
BE | -2 mmol/L |
ScvO2 | 89.10 % |
Volume of input | 3677 ml |
Volume of output | 5520 ml |
Volume of urine | 5450 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 12 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 20 mg |
Levosimendan | no
|
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | mm |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 5.50 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 11.91 |
PH value | 7.52 |
PaO2 | 106 mmHg |
PaCO2 | 27.5 mmHg |
BE | -0.1 mmol/L |
SaO2 | 98.90 % |
Blood Lactic Acid Concentration | 1.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 265 mmHg |
PH value | 7.49 |
PcvO2 | 67 mmHg |
PcvCO2 | 33 mmHg |
BE | 1.1 mmol/L |
ScvO2 | 90.10 % |
Volume of input | 5266 ml |
Volume of output | 8380 ml |
Volume of urine | 8250 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 12 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 20 mg |
Levosimendan | no
|
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
IVC(inspiratory phase) | mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | 7.06 ng/ml |
Creatine kinase isoenzyme, CKMB | 52 U/L |
Creatinine | 119 umol/L |
Urea nitrogen | 11.6 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 10.3 X10*9/L |
neutrophilic granulocyte percentage | 91.1 % |
Hb | g/L |
CRP | 0.5 mg/L |
Procalcitonin, PCT | 0.136 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | 14.912 ng/ml |
Creatine kinase isoenzyme, CKMB | 19 U/L |
Creatinine | 114 umol/L |
Urea nitrogen | 9.8 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 8 X10*9/L |
neutrophilic granulocyte percentage | 90.9 % |
Hb | g/L |
CRP | 64.54 mg/L |
Procalcitonin, PCT | ng/ml |
Sequential Organ Failure Assessment | 13 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | 4.75 ng/ml |
Creatine kinase isoenzyme, CKMB | 8 U/L |
Creatinine | 111 umol/L |
Urea nitrogen | 13.4 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 904 X10*9/L |
neutrophilic granulocyte percentage | 94.1 % |
Hb | g/L |
CRP | 231.89 mg/L |
Procalcitonin, PCT | ng/ml |
Sequential Organ Failure Assessment | 8 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 10 分 |
Complication | no
|
prognosis | department transference
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 28 天 |
duration in ICU | 7 天 |
duration of mechanical ventilation | 150 小时 |
ICU expenses | 56800 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 0 小时 |